|
Diabetes Care, Vol 20, Issue 5 875-880, Copyright © 1997 by American Diabetes Association
Incomplete elimination of the ABBOS epitope of bovine serum albumin under simulated gastrointestinal conditions of infants
AC Alting, RJ Meijer and EC van Beresteijn
Department of Biophysical Chemistry, Netherlands Institute for Dairy Research, Ede, The Netherlands. alting@nizo.nl
OBJECTIVE: Because the bovine serum albumin residues 126-144 (ABBOS) have
been reported to be responsible for the autoimmune reaction directed
against pancreatic islet cells, it was our aim to study the potential
survival of the ABBOS epitope during digestion in the gastrointestinal
tract. RESEARCH DESIGN AND METHODS: Either nontreated (commercially
available) or heat-treated bovine serum albumin (BSA) was hydrolyzed in
vitro with pepsin at a pH of 2.0, 3.0, and 4.0 and subsequently with
pancreatic enzymes at a pH of 7.5. Cross-reactivity between the ABBOS
peptide and the BSA hydrolysates was determined by competitive
enzyme-linked immunosorbent assay (ELISA) using a rabbit polyclonal
antibody raised against the ABBOS peptide in BSA. RESULTS: Biochemical
findings clearly showed that the degradation of BSA during simulated
physiological digestion depended on its conformation and on the pH of its
pepsin-catalyzed hydrolysis. Raising the pH of the pepsin-catalyzed
hydrolysis from 2.0 to 4.0 decreased the efficiency of the process,
especially when BSA had first been denatured by heat treatment. As a
consequence, a large proportion of the cross-reactive anti-ABBOS
antibody-binding sites was still intact in the final hydrolysates.
CONCLUSIONS: The present results suggest that the ABBOS epitope of BSA will
not be completely eliminated during digestion under conditions that prevail
in the stomach of infants (pH 3-4).

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Hayes, C. Stanton, H. Slattery, O. O'Sullivan, C. Hill, G. F. Fitzgerald, and R. P. Ross
Casein Fermentate of Lactobacillus animalis DPC6134 Contains a Range of Novel Propeptide Angiotensin-Converting Enzyme Inhibitors
Appl. Envir. Microbiol.,
July 15, 2007;
73(14):
4658 - 4667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Quiros, B. Hernandez-Ledesma, M. Ramos, L. Amigo, and I. Recio
Angiotensin-Converting Enzyme Inhibitory Activity of Peptides Derived from Caprine Kefir
J Dairy Sci,
October 1, 2005;
88(10):
3480 - 3487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Winer, I. Astsaturov, R. K. Cheung, K. Schrade, L. Gunaratnam, D. D. Wood, M. A. Moscarello, P. O'Connor, C. McKerlie, D. J. Becker, et al.
T Cells of Multiple Sclerosis Patients Target a Common Environmental Peptide that Causes Encephalitis in Mice
J. Immunol.,
April 1, 2001;
166(7):
4751 - 4756.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Winer, L. Gunaratnam, I. Astsatourov, R. K. Cheung, V. Kubiak, W. Karges, D. Hammond-McKibben, R. Gaedigk, D. Graziano, M. Trucco, et al.
Peptide Dose, MHC Affinity, and Target Self-Antigen Expression Are Critical for Effective Immunotherapy of Nonobese Diabetic Mouse Prediabetes
J. Immunol.,
October 1, 2000;
165(7):
4086 - 4094.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|